Amanote Research

Amanote Research

    RegisterSign In

Current Management of Primary Immune Thrombocytopenia

Advances in Therapy - United States
doi 10.1007/s12325-015-0251-z
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicinePharmacology
Date

October 1, 2015

Authors
Drew ProvanAdrian C. Newland
Publisher

Springer Science and Business Media LLC


Related search

Management of Primary Immune Thrombocytopenia, 2012: A Survey of Oklahoma Hematologists-Oncologists

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Immune Thrombocytopenia

Hospital Medicine Clinics
Medicine
2017English

Switching Thrombopoietin Receptor Agonist Treatments in Patients With Primary Immune Thrombocytopenia

Therapeutic Advances in Hematology
Hematology
2019English

A Blinded Study of Bone Marrow Examinations in Patients With Primary Immune Thrombocytopenia

European Journal of Haematology
MedicineHematology
2012English

Methylprednisolone‐induced Immune Thrombocytopenia

American Journal of Hematology
Hematology
2019English

Babesiosis-Associated Immune Thrombocytopenia

Stem Cell Investigation
2017English

Primary Immune Thrombocytopenia Responding to Antithyroid Treatment in a Patient With Graves’ Disease

Annals of Hematology
MedicineHematology
2010English

Thromboembolism in Adults With Primary Immune Thrombocytopenia: A Systematic Literature Review and Meta-Analysis

European Journal of Haematology
MedicineHematology
2016English

Immune Thrombocytopenia in Lymphoproliferative Diseases

Blood
BiochemistryImmunologyCell BiologyHematology
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy